Generic Pharmaceuticals Businesses for Sale and Investment

Drug manufacturing business based in Hyderabad. - Company has around 60% spare capacity that can be immediately utilised for interested investors. - The average order value is INR 15L and we are supplying to 30 pharmaceutical companies. - We have all the licenses like factory license, pollution control board and drug license. - Having in-house solvent recovery facilities enables optimum solvent recoveries and minimizes handling losses. - Licensed Capacity: Large capacity of 930 MT p. a. can cater to future expansions without going for any fresh statutory approvals. - GMP Local GMP from DCA, Telangana. Facility can be easily scaled to WHO GMP & other regulatory approvals. - Private limited company is not part of the sale.

Drug manufacturing business based in Hyderabad. - Company has around 60% spare capacity that can be immediately utilised for interested investors. - The average order value is INR 15L and we are supplying to 30 pharmaceutical companies. - We have all the licenses like factory license, pollution control board and drug license. - Having in-house solvent recovery facilities enables optimum solvent recoveries and minimizes handling losses. - Licensed Capacity: Large capacity of 930 MT p. a. can cater to future expansions without going for any fresh statutory approvals. - GMP Local GMP from DCA, Telangana. Facility can be easily scaled to WHO GMP & other regulatory approvals. - Private limited company is not part of the sale.

We have been manufacturing cum sales suppliers to 165+ hospitals cum dialysis centers. - We have 18 hemodialysis products and also sell to 2 outsourced dialyzer cleaning solutions. - Manufacturing capacity is over 5 crore litres annually. - We comply with all the regulatory requirements applicable to the products. - The company is registered in Mumbai but the operations are based out of Bhiwandi.

The two main partners sold their stake in a previous company almost 10 years back and have now created their own new company. - They hold over 40 patents and are on the verge of their first approved generic complex injectable drug in a couple of months. - The facility was inspected very recently by the FDA and passed. - We have 5 drugs pending approval with a total market value of over USD 4B and only a few competitors. - The company should be worth USD 2B in another 3 years. - The business has not generated any revenue because we have been in the process of R&D in developing these drugs for the past 6 years and have invested over USD 40 million in the business.

Developed highly niche products with almost no worldwide competition. All products have 50-60% profit margins going up to 200% profit margin. Fits in low volume - High margin product category. We cannot expand due to financial restrictions only & lack of 4-5 months working capital. Plant is already 80% FDA complaint & we surrendered our FDA linense in 2015. With some capex involvement, this can me FDA & GMP complaint within months and with adequate working capital one can keep ready stock & expand internationally. We will also give you buyers of each product.

Pioneers in the pharmacy business known for world-class, quality, and efficacious medicines. - We are located on an owned property with fully functional industrial standard machinery, equipment, and all the relevant license to practice medicine manufacturing. - Business was stopped for a few years last year as we were focussing on another business. - Products are manufactured and sold under our own brand name. - Production capacity of the facility is 40,000 syrup bottles per day but we are utilizing a very small part of the capacity at the moment. - Products are sold to wholesalers, retail stores, traders, and distributors.

Pharma marketing company and virtual manufacturer of nutraceuticals and generic pharma medicines. - Have 21 brands registered under our own name along with their trademarks. - Third-party manufacturing, all our products are WHO and GMP certified. - Mostly on-ground sales work where we visit hospitals, clinics, and onboard doctors to prescribe our products. - We have more than 50 doctors as our prescribers. - Strong distributor network in Delhi NCR, we have around 5 distributors. - Payment terms are negotiated with each client. - Business loan of INR 5 lakh is being repaid at the moment. - Two owners with equal shareholding. - Business had reached a pre-Covid revenue of INR 72 lakh. The company had exponential growth in the pre-Covid years. - Covid affected operations as we could not deploy our sales team to visit hospitals and clinics. - We are a fast-paced organization and wish to get this funding by the end of this financial year.

Our pharma company is recognized by Global Vegetarian, a Halal-certified company that also has brands registered in Kenya. - We get our products manufactured from a third party under our own brand name. - Product promotion and sales are done with the help of tie-ups with the doctors and currently, we have tie-ups with more than 50 doctors for the same. - Our revenue is increasing gradually with the recognition of the brand in the market. - The company is completely liabilities-free and is solely owned by the user only.

Our company outsources the manufacturing of generic pharmaceuticals which are then supplied to our customers under our trademarked brand names. - The manufacturing is outsourced from 10 manufacturers in Haridwar, Chandigarh, and Himachal Pradesh. They package the final products under our brand names and send them to us. All the products are proprietary and exclusive to our company. - Currently, we have about 8 different general medicines under our company. The intellectual property and patents on the chemical formulations of these medicines are owned by us. We used a third-party pharmaceutical company for helping us develop the drug. All the products are approved by CDSCO. - The promoters have a long-standing experience in the pharmaceutical industry which led them to bootstrap their own company. - Each of the medicine is sold under a different name. All 8 names have been trademarked and we possess their ownership. There is an equal production and demand of all the products. There are 5 to 7 more drugs under development and will be launched in the upcoming months. - Our products are sold to about 100 distributors who further sell them to pharmacy stores across Uttarakhand, Madhya Pradesh, and Delhi. This is the only source of revenue for our company. We have not begun any direct-to-consumer sales yet. We receive anywhere between 60 to 70 purchase orders of varied sizes every month. - The business is extremely valuable due to our fleet of patented drugs, more drugs in the pipeline, and constant growth in the business. The valuation is based on our own estimate.

Company manufactures generic pharmaceuticals for leading pharmaceutical companies. - Has more than 20 clients across Asia, Middle East, Africa and America. - Manufacturing capacity is 90,000 capsules per hour with latest equipment. Detailed capacities can be shared with interested parties upon introduction. - Company is established with an objective to provide unique product propositions which meets the customer requirements and expectations. - The unit is located at strategic location considering Gujarat a hub of various pharma giants. The existing manufacturing facility is equipped with latest technology for supreme manufacturing arrangement. - It has all valid license in terms of sales and export and approvals from WHO and FDA. - Company is a member of Pharmexcil (India) and Anti Microbial Resistance Industry Alliance (Switzerland). - The high growth in sales compared to last year is due to various factors including better economic situation with respect to the pandemic, increase number of approvals, capacity and clients. - Valuation is based on rapid growth rate and approvals. Company has applied for the European market approval which will open a door to new markets and client base. Company has the capacity to cater higher demands and requirements.